Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition.

Institutions FC
Department of Experimental Therapy, FAU, Germany 0.23
Department of Experimental Medical Science, LU, Sweden 0.10
Novartis Pharma AG, Switzerland 0.10
Department of Physiology and Pharmacology, KI, Sweden 0.06
Bio-Imaging Laboratory, UA, Belgium 0.06
Charité Institute of Medical Genetics and Human Genetics, Germany 0.06
McKnight Brain Institute (MBI), UF, United States of America (USA) 0.06
Centre for Rare Diseases (ZSE), Uni Tübingen, Germany 0.05
Institute of Medical Genetics and Applied Genomics, Uni Tübingen, Germany 0.05
Institute of Neuroscience and Medicine (INM), FZJ, Germany 0.03
Department of Biochemistry and Cellular and Molecular Biology (BCMB), UTK, United States of America (USA) 0.03
Clinic for Psychosomatics and Psychotherapy, MHH, Germany 0.03
Institute for Molecular Regenerative Medicine, PMU, Austria 0.03
European Cancer Stem Cell Research Institute, Cardiff University, United Kingdom (UK) 0.03
School of Biosciences, Cardiff University, United Kingdom (UK) 0.03
Institute of Experimental Neuroregeneration, PMU, Austria 0.02
Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), PMU, Austria 0.02
Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA), United States of America (USA) 0.02

Return